의약품 부형제 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 기능별, 제제 형태별, 원료별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Pharmaceutical Excipients Market size was valued at USD 10.12 Billion in 2024 and is poised to grow from USD 10.81 Billion in 2025 to USD 18.29 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global pharmaceutical excipients market is experiencing significant shifts fueled by advancements in drug development and the demand for more effective, stable formulations. Excipients are evolving from mere fillers to crucial components that enhance drug efficacy and patient adherence. As active pharmaceutical ingredients become increasingly complex-particularly in biologics and highly potent formulations-there's a growing need for excipients that support improved solubility, bioavailability, and targeted delivery. The industry is also focusing on enhancing formulation performance and stability through controlled-release and taste-masked systems. This evolution is spurring the adoption of functional and co-processed excipients that offer multiple benefits. Regulatory scrutiny is intensifying around excipient quality, promoting the use of GMP-compliant materials, while harmonized frameworks are paving the way for new entrants into the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Excipients Market Segments Analysis

Global pharmaceutical excipients market is segmented into product type, functionality, formulation, source, end user and region. Based on product type, the market is segmented into organic chemicals, inorganic chemicals and others. Based on functionality, the market is segmented into binders, fillers/diluents, disintegrants, coating agents, lubricants, preservatives, flavours and sweeteners, colouring agents, solvents and others. Based on formulation, the market is segmented into oral formulations, topical formulations, parenteral formulations, inhalation formulations, ophthalmic formulations, nasal formulations and suppositories. Based on source, the market is segmented into natural and synthetic. Based on end user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, contract manufacturing organizations (CMOs) and contract research organizations (CROs). Based on region the market is segmented as, North America, Asia Pacific, Europe, Latin America, Middle East and Africa.

Driver of the Global Pharmaceutical Excipients Market

One of the key market drivers for the global pharmaceutical excipients market is the growing demand for advanced drug formulations that enhance bioavailability and patient compliance. As pharmaceutical companies increasingly focus on developing complex oral and parenteral dosage forms, the need for high-quality excipients becomes paramount. Innovations in excipient technologies, such as the development of multifunctional excipients that can serve multiple purposes-such as improving solubility, stability, and release profiles-are driving growth. Additionally, the rising prevalence of chronic diseases necessitates the creation of tailored medication solutions, further propelling the demand for specialized excipients in the pharmaceutical sector.

Restraints in the Global Pharmaceutical Excipients Market

One of the key market restraints for the global pharmaceutical excipients market is the stringent regulatory framework imposed by health authorities worldwide. These regulations are designed to ensure the safety, efficacy, and quality of pharmaceutical products, which can lead to lengthy approval processes for new excipients. This complexity can deter manufacturers from developing innovative excipients due to the significant time and financial investment required to comply with regulatory requirements. Additionally, the costs associated with rigorous testing and documentation further constrain smaller companies, creating barriers to entry in a market increasingly dominated by a few large players.

Market Trends of the Global Pharmaceutical Excipients Market

The Global Pharmaceutical Excipients market is witnessing a notable trend towards the adoption of multifunctional and co-processed excipients, driven by the need for streamlined formulation processes and enhanced product performance. Pharmaceutical companies are increasingly opting for excipients that integrate multiple properties, such as binding, disintegration, and flowability, to optimize manufacturing efficiency and performance. Co-processed excipients, achieved through the physical blending of various components at the microscopic level, offer improved mechanical strength and compressibility, leading to better tablet uniformity and enabling complex dosage forms. This shift underscores a broader industry emphasis on innovation and efficiency in drug formulation and development.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Pharmaceutical Excipients Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Organic Chemicals
• Inorganic Chemicals
• Others

Global Pharmaceutical Excipients Market Size by Functionality & CAGR (2026-2033)

• Market Overview
• Binders
• Fillers/Diluents
• Disintegrants
• Coating Agents
• Lubricants
• Preservatives
• Flavors and Sweeteners
• Coloring Agents
• Solvents

Global Pharmaceutical Excipients Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Oral Formulations
• Topical Formulations
• Parenteral Formulations
• Inhalation Formulations
• Ophthalmic Formulations
• Nasal Formulations
• Suppositories

Global Pharmaceutical Excipients Market Size by Source & CAGR (2026-2033)

• Market Overview
• Natural
• Synthetic

Global Pharmaceutical Excipients Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Contract Research Organizations (CROs)

Global Pharmaceutical Excipients Market Size & CAGR (2026-2033)

• North America (Product Type, Functionality, Formulation, Source, End User)
  • US
  • Canada
• Europe (Product Type, Functionality, Formulation, Source, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Functionality, Formulation, Source, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Functionality, Formulation, Source, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Functionality, Formulation, Source, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• BASF SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dow Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ashland Global Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JRS Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glenmark Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ichnos Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Signet Chemical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CP Kelco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IMCD Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACG Worldwide
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azelis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmablock Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fagron
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Suven Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations